Evidence map›Paper›PMID 22642491›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2012

Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.

S K Ramakrishnan, A Page, A B Farris, K Singh, F Leopardi, K Hamby, S Sen, A Polnett, T Deane, M Song and 5 more

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Article
  4. Review
  5. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014
    Article
  6. Transplantation tolerance.Pediatric nephrology (Berlin, Germany) · 2014
    Review
  7. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2014
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

S K RamakrishnanThe Emory Transplant Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
A Page
A B Farris
K Singh
F Leopardi
K Hamby
S Sen
A Polnett
T Deane
M Song
L Stempora
E Strobert
A D Kirk
C P Larsen
L S Kean
Emory Healthcare · USEmory University · USHealth First · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Transplant Tolerance in Non-Human PrimatesU19AI051731 · NIAID · UNIVERSITY OF WESTERN ONTARIO · PI LARSEN, CHRISTIAN P. · 2002 to 2022
$54.1M
SPF BREEDING COLONIES AT THE YERKES NPRC: AIDS, THERAPEUTIC AGENT DVMTU24RR018109 · NCRR · EMORY UNIVERSITY · PI ELSE, JAMES GIBSON · 2002 to 2011
$13.8M
Novel Biologic Therapies for GVHDR01HL095791 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI KEAN, LESLIE S · 2010 to 2025
$13.3M
Adjuvant Therapies Improving the Anti-Rejection Effects of Costimulation BlockadeU01AI079223 · NIAID · EMORY UNIVERSITY · PI KIRK, ALLAN D. · 2009 to 2012
$2.4M
Innate Immunity and Transplantation ToleranceK08AI065822 · NIAID · EMORY UNIVERSITY · PI KEAN, LESLIE S · 2006 to 2009
$476k
NCRR NIH HHS P51 RR000165NCRR NIH HHS RR00165NCRR NIH HHS U24 RR018109NHLBI NIH HHS 1R01 HL095791NHLBI NIH HHS R01 HL095791NIAID NIH HHS 1U01AI079223NIAID NIH HHS 5K08 AI065822NIAID NIH HHS 5U19 AI051731NIAID NIH HHS HHSN272200900037CNIAID NIH HHS K08 AI065822NIAID NIH HHS U01 AI079223NIAID NIH HHS U19 AI051731
6 · The paper itself

Abstract

Although there is evidence linking hematopoietic chimerism induction and solid organ transplant tolerance, the mechanistic requirements for chimerism-induced tolerance are not clearly elucidated. To address this, we used an MHC-defined primate model to determine the impact of impermanent, T cell-poor, mixed-chimerism on renal allograft survival. We compared two cohorts: one receiving a bone marrow and renal transplant ("BMT/renal") and one receiving only a renal transplant. Both cohorts received maintenance immunosuppression with CD28/CD40-directed costimulation blockade and sirolimus. As previously demonstrated, this transplant strategy consistently induced compartmentalized donor chimerism, (significant whole-blood chimerism, lacking T cell chimerism). This chimerism was not sufficient to prolong renal allograft acceptance: the BMT/renal mean survival time (MST, 76 days) was not significantly different than the renal transplant alone MST (85 days, p = 0.46), with histopathology documenting T cell mediated rejection. Flow cytometric analysis revealed significant enrichment for CD28-/CD95+ CD4+ and CD8+ Tem cells in the rejected kidney, suggesting a link between CD28-negative Tem and costimulation blockade-resistant rejection. These results suggest that in some settings, transient T cell-poor chimerism is not sufficient to induce tolerance to a concurrently placed renal allograft and that the presence of this chimerism per se is not an independent biomarker to identify tolerance.

Indexed as

Bone Marrow TransplantationChimerismGraft RejectionKidney TransplantationAnimalsMacaca mulattaTransplantation, Homologous

Identifiers

PMID22642491
PMCPMC3387328
OpenAlexW1826590395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.